FFCP PHASE1:Hg19::chr10:20017380..20017395,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=83bp_to_ENST00000423551,ENST00000431157,ENST00000451713,uc001iqf.2_5end | |||
|cluster_id=chr10:20017380..20017395,- | |||
|coexpression_cluster_id=C975 | |||
|description=CAGE_peak_3_at_ENST00000423551_5end,CAGE_peak_3_at_ENST00000431157_5end,CAGE_peak_3_at_ENST00000451713_5end,CAGE_peak_3_at_uc001iqf.2_5end | |||
|id=chr10:20017380..20017395,- | |||
|ontology_enrichment_celltype=CL:0002274!1.06e-22!5;CL:0000457!1.06e-22!5;CL:0002191!1.06e-22!5;CL:0000097!1.06e-22!5;CL:0000831!1.06e-22!5;CL:0002028!1.06e-22!5;CL:0000163!1.83e-12!9;CL:0000763!9.40e-12!112;CL:0000049!9.40e-12!112;CL:0000764!2.99e-09!2;CL:0000765!2.99e-09!2;CL:0000050!2.99e-09!2;CL:0000038!2.99e-09!2;CL:0000558!2.99e-09!2;CL:0000547!2.99e-09!2;CL:0000549!2.99e-09!2;CL:0000550!2.99e-09!2;CL:0000552!2.99e-09!2;CL:0000037!1.26e-07!172;CL:0000566!1.26e-07!172;CL:0000988!6.22e-07!182;CL:0000540!7.61e-07!6;CL:0000031!7.61e-07!6;CL:0000404!7.61e-07!6 | |||
|ontology_enrichment_celltype_v019=CL:0000097;8.26e-49;5!CL:0000163;3.86e-27;9!CL:0000037;1.40e-10;1!CL:0001024;1.40e-10;1!CL:0000763;1.23e-09;100!CL:0000540;4.44e-07;6!CL:0000404;4.44e-07;6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000097,8.27e-49,5;CL:0002028,8.27e-49,5;CL:0000163,3.86e-27,9;CL:0000763,2.28e-17,108;CL:0000049,2.28e-17,108;CL:0000037,6.18e-12,168;CL:0000988,3.36e-11,177;CL:0002032,6.84e-11,161;CL:0000837,6.84e-11,161;CL:0001024,1.33e-10,1;CL:0000540,4.58e-07,6;CL:0000031,4.58e-07,6;CL:0000404,4.58e-07,6 | |||
|ontology_enrichment_development_v019=CL:0000031;4.44e-07;6 | |||
|ontology_enrichment_disease=DOID:8692!5.76e-24!31;DOID:1036!1.02e-18!8;DOID:1240!2.24e-18!39;DOID:2531!2.70e-13!51;DOID:0060083!2.70e-13!51 | |||
|ontology_enrichment_disease_v019=DOID:8692;1.02e-27;31!DOID:1240;1.15e-17;39!DOID:2531;6.61e-12;51!DOID:0060083;6.61e-12;51!DOID:1036;1.84e-11;8!DOID:8552;9.97e-11;1!DOID:9119;1.40e-10;1 | |||
|ontology_enrichment_disease_v019_2=DOID:8692,4.97e-29,31;DOID:1240,8.54e-23,39;DOID:2531,4.22e-17,51;DOID:0060083,4.22e-17,51;DOID:1036,1.80e-11,8;DOID:8552,9.97e-11,1;DOID:9119,1.61e-10,1 | |||
|ontology_enrichment_uberon=UBERON:0007023!4.89e-07!115 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.46800219667424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.8954195721123,7.28661131875997,4.21414535640123,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.5451207495485,28.9679347903514,23.0134208250257,24.0680322206326,19.4413347476625,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.54657762555539,0.335032530668698,1.27587750330633,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.106727557803444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.657779629937804,0.261435451024901,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.3781273145065,0.383010740264733,0,0,1.40398589056729,0,0,0,0,0,0,0,0,0,0,0,0,1.67043704337145,0,10.8182271390393,1.33228787199128,12.6888304579065,0,0,0,0,0,0,0,0,0,0,0,0,0,0.19924798825107,0,0,0,0,0,0,0,0,0.0986434056369336,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.153900517007594,0,0,0,0,0,0,0,0,42.2276889702617,3.98908036560375,0.225595660617181,0.19606253431774,0,0.948768663620925,10.6487507916854,0,0,0,0,0,0.0884575645033392,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063186579628488,0,0,0,0,0,0,0,0,0,0,0,0.17472666824203,0,0,0,0,0.193978032976839,0,0.225980740780532,0,0,0,0,0,0.426905989478705,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.88088199193654,0,0,0,0,0,0,0,0,0.427149650270779,0,0.414239055347196,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0752103283492573,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.342976018874837,0,0,0,0,0.39246546425257,0,0,0,0,0,0.214429632529969,0.158013611732727,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.102662806856247,0,0,0,0,0,0,0,0,0,0.218559560503957,0,0.490296643507811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0717222053926763,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p3@ENST00000423551,p3@ENST00000431157,p3@ENST00000451713,p3@uc001iqf.2 | |||
}} |
Latest revision as of 12:26, 23 July 2015
Short description: | p3@ENST00000423551, p3@ENST00000431157, p3@ENST00000451713, p3@uc001iqf.2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_ENST00000423551_5end, CAGE_peak_3_at_ENST00000431157_5end, CAGE_peak_3_at_ENST00000451713_5end, CAGE_peak_3_at_uc001iqf.2_5end |
Coexpression cluster: | C975_Mast_chronic_CD34_acute_leukemia_CD133_Whole |
Association with transcript: | 83bp_to_ENST00000423551, ENST00000431157, ENST00000451713, uc001iqf.2_5end |
EntrezGene: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mast cell | 8.27e-49 | 5 |
basophil mast progenitor cell | 8.27e-49 | 5 |
endocrine cell | 3.86e-27 | 9 |
myeloid cell | 2.28e-17 | 108 |
common myeloid progenitor | 2.28e-17 | 108 |
hematopoietic stem cell | 6.18e-12 | 168 |
hematopoietic cell | 3.36e-11 | 177 |
hematopoietic oligopotent progenitor cell | 6.84e-11 | 161 |
hematopoietic multipotent progenitor cell | 6.84e-11 | 161 |
CD34-positive, CD38-negative hematopoietic stem cell | 1.33e-10 | 1 |
neuron | 4.58e-07 | 6 |
neuroblast | 4.58e-07 | 6 |
electrically signaling cell | 4.58e-07 | 6 |
Ontology term | p-value | n |
---|---|---|
myeloid leukemia | 4.97e-29 | 31 |
leukemia | 8.54e-23 | 39 |
hematologic cancer | 4.22e-17 | 51 |
immune system cancer | 4.22e-17 | 51 |
chronic leukemia | 1.80e-11 | 8 |
chronic myeloid leukemia | 9.97e-11 | 1 |
acute myeloid leukemia | 1.61e-10 | 1 |